Mayor Bill de Blasio signed an executive order Tuesday that raises the hourly rate from under $11.90 to $13.13 an hour for thousands of fast-food and retail workers.
Commerce and payments are splitting up. Ebay is breaking away from PayPal and its payments operation will turn into a separate, publicly traded company.
Weary employees could need more than just time off to re-energize. Some employers have ditched the time cards, let workers set their own schedules or allow them to rotate jobs to prevent burnout.
A federal website set to go live Tuesday will disclose drug and device companies' ties to doctors. The release marks a milestone, but could be misleading for patients checking up on their doctors.
It has been nearly 2 months since Argentina defaulted on its debt. And now a judge in New York has held Argentina in contempt for proceeding with plans to pay some of its bondholders, but not others.
Most U.S. poultry is bathed in a little chlorine on the way to your plate. But that treatment is banned in Europe. Now "chlorinated chickens" are a sticking point in a trans-Atlantic trade deal.
Large-scale hog operations get a bad environmental rap. But when it comes to processing the animals, the industry is a model of efficiency, making use of every last bit in sometimes surprising ways.
The NFL has become a $10 billion financial juggernaut by attracting new fans and devising new ways to make money. Now, the NFL confronts what may be its most serious image problem ever.
Rochester, N.Y., was once the imaging capital of the world, home to Kodak, Xerox and Bausch + Lomb. Now, with a drastically cut manufacturing sector, the city is trying to build something new.
Domestic movie ticket sales seem to have topped out. Now, cinema owners are trying to lure customers — and justify higher ticket prices — with innovations like panoramic screens and so-called 4-D.
A typical residential customer, who uses 500 kilowatt hours a month, could see their bill rise about $33 a month.
A Chelsea biotech drug company, which developed a Parkinson’s disease drug, is ditching Wall Street for deeper pockets up the road in Ardsley, N.Y.